Gaurav Rana (@drgauravrana) 's Twitter Profile
Gaurav Rana

@drgauravrana

Interventional Cardiologist @BalladHealth Special Interest: Structural Heart Disease, Vascular/ Endovascular Medicine. Tweets@my views, no medical advice.

ID: 169327419

calendar_today22-07-2010 02:27:46

351 Tweet

345 Followers

367 Following

Gaurav Rana (@drgauravrana) 's Twitter Profile Photo

Thank you Yuvraj Singh for all the memories of World Cup while coughing and hemoptysis due to cancer (still won man of series), T20, champions trophy, Natwest finals. You are the strongest sportsperson I know. Yuvraj Singh Best finisher in cricket!!

Gaurav Rana (@drgauravrana) 's Twitter Profile Photo

TOBA II-BTK showed some amazing promise in below the knee interventions. Gutsy trial to check RB class 4,5 patients in CLI. Look forward to long term data, but even in 6 m this is impressive. The VIVA Foundation

TOBA II-BTK showed some amazing promise in below the knee interventions. Gutsy trial to check RB class 4,5 patients in CLI. Look forward to long term data, but even in 6 m this is impressive. <a href="/VIVAPhysicians/">The VIVA Foundation</a>
Robert W. Yeh (@rwyeh) 's Twitter Profile Photo

1/Lot's of angst about #ISCHEMIA and what it will mean for cardiology practice. For me, a positive trial is likely to mean more for changing my practice than a negative one. I'll try to explain (Thread). #AHA19

Gregg W. Stone MD (@greggwstone) 's Twitter Profile Photo

COLCOT results: 4745 recent MI pts rand to colchicine vs placebo. Primary endpoint of CV death, MI, stroke,arrest or urgent hosp for revasc reduced by 28%, with all components in the right direction! Mean FU 23 mo. No major adverse events. Wow!

COLCOT results: 4745 recent MI pts rand to colchicine vs placebo.  Primary endpoint of CV death, MI, stroke,arrest or urgent hosp for revasc reduced by 28%, with all components in the right direction! Mean FU 23 mo. No major adverse events. Wow!
John Rundback, MD (@jrunmd) 's Twitter Profile Photo

Tweetorial #1. Learned at #ISET. R3 PAD w acute exacerbation, easy wire crossing ... aspiration thrombectomy w DEB changes CTO to stenosis, great final result, no emboli!!!

Tweetorial #1.  Learned at #ISET.  R3 PAD w acute exacerbation, easy wire crossing ... aspiration thrombectomy w DEB changes CTO to stenosis, great final result, no emboli!!!
Dr. Glaucomflecken (@dglaucomflecken) 's Twitter Profile Photo

It's possible in the coming days that specialists may be called upon to help out our critical care colleagues, so I thought I'd share a few tips for my fellow ophthalmologists on how to manage a ventilator. Hope this helps...

Amy Klobuchar (@amyklobuchar) 's Twitter Profile Photo

Doctors across the country on visas are willing to risk their lives to help others right now. But visa program restrictions are standing in the way. We need to make sure qualified people can help so our health care system is prepared during this emergency. politico.com/politicopulse/

Greg Siskind (@gsiskind) 's Twitter Profile Photo

1 - I'm glad Business Insider wrote this story, but USCIS misled the reporter regarding a critical issue - If doctors in the US on visas die while fighting the coronavirus, their families could be forced to leave the country or face deportation businessinsider.com/foreign-doctor…

The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

VIVA Goes Virtual: Save the Date Global Session: November 6-8 PharmacoRx: November 10 and 12 AV Dialysis: November 12 CLI: November 14 The VEINS November 14-15 Explore the new agenda, review accreditation information, and more: vivaphysicians.org/news-article?i…

VIVA Goes Virtual: Save the Date

Global Session: November 6-8
PharmacoRx: November 10 and 12
AV Dialysis: November 12
CLI: November 14

The VEINS
November 14-15

Explore the new agenda, review accreditation information, and more: vivaphysicians.org/news-article?i…
Andrew J Sauer MD (@andrewjsauer) 's Twitter Profile Photo

My top ten tips for graduating fellows and faculty entering and continuing “early career” as I am transitioning into “mid-career”. A thread:

Navin Kapur (@navinkapur4) 's Twitter Profile Photo

Are you DTU? Thank you #CSRC for the opportunity to discuss #cardiogenicshock trials. Started by pointing out that #STEMI-DTU enrolls SCAI Shock A/B patients with an endpoint looking at progression to SCAI C-E shock. Great illustration of this by #DTU Operator Gaurav Rana

Are you DTU? Thank you #CSRC for the opportunity to discuss #cardiogenicshock trials. Started by pointing out that #STEMI-DTU enrolls <a href="/SCAI/">SCAI</a> Shock A/B patients with an endpoint looking at progression to SCAI C-E shock. Great illustration of this by #DTU Operator <a href="/drgauravrana/">Gaurav Rana</a>
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

From quadrapelegic to being back in the cath lab: Dr. Dean Kereiakes courageously shares his journey of chronic and acute spinal cord injury caused by decades of wearing led as a stark warning to young interventional cardiologists who think they are unbreakable ... you are not